"The Global Artificial Pancreas Market size is estimated to reach at a CAGR of 11% during the forecast period (2024-2031)." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The artificial pancreas market is set for substantial growth through 2031, fueled by the rising global prevalence of diabetes and increased demand for automated blood glucose control. Technological advancements in sensors, insulin pumps, and AI-powered algorithms are driving innovation and reliability in closed-loop systems. Enhanced patient comfort and accuracy are also attracting wider clinical acceptance. The shift toward hybrid and fully automated systems is opening new commercial segments. Moreover, emerging markets are expected to contribute significantly as healthcare infrastructure and awareness improve.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/artificial-pancreas-market?pratik

Artificial Pancreas Market: Recent Industry Developments

✅In March 2025: Researchers published a reinforcement learning optimized fuzzy controller (Takagi-Sugeno model), improving adaptability to meal variation and stabilizing glucose in simulation environments suggesting future enhancements in AP algorithms.

✅In January-July 2025: While FDA clearance (June 2024) predates our window, in 2025 Omnipod 5 saw expanded support for Dexcom G7 CGM and the Omnipod app for iPhone, increasing accessibility and user control for both T1D and T2D users as the smartphone ecosystem stabilized

✅In 2025: Zealand Pharma initiated a Phase IIa trial of its stable glucagon analogue (dasiglucagon) integrated within Beta Bionics' dual-hormone iLet Bionic Pancreas system. This is the fourth Phase II trial this year, designed to test safety and efficacy in adults with type 1 diabetes. Clinical results are expected in Q1 2026.

Artificial Pancreas Market: Market Drivers

Growing diabetes cases worldwide are accelerating the need for smart and automated insulin delivery solutions. Regulatory approvals for next-gen devices such as hybrid closed-loop systems are boosting market confidence. Technological integration of AI and real-time data is improving therapy precision and safety. Favorable reimbursement policies and rising healthcare spending support adoption in developed regions. Patients increasingly prefer user-friendly systems that minimize hypoglycemic risks and reduce the burden of self-management.

Strategic Players Driving the Artificial Pancreas Market Forward:

✦ Medtronic PLC
✦ Johnson & Johnson
✦ Tandem Diabetes Care, Inc.
✦ Pancreum, Inc.
✦ Bigfoot Biomedical, Inc.
✦ DexCom, Inc.
✦ Beta Bionics, Inc.
✦ Admetsys Corp.
✦ Insulet Corporation
✦ Defymed

Segment Covered in the Artificial Pancreas Market:

➥By Type: Threshold Suspend Device Systems, Non-threshold Suspend Device Systems, Control to Range Systems, Control to Target Systems

Why Purchase the Report for Artificial Pancreas Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Regional Analysis for Artificial Pancreas Market:

North America leads the global artificial pancreas market due to its strong research ecosystem, high diabetes burden, and early adoption of innovative technologies. Europe ranks as the second-largest market with strong reimbursement frameworks and well-established healthcare systems. Asia-Pacific is the fastest-growing region, driven by increasing diabetes prevalence, rising healthcare investments, and growing demand for automated disease management solutions.

Conclusion:

The artificial pancreas market is evolving rapidly, with breakthroughs in automation and digital health transforming diabetes care. As devices become more intelligent and patient-centric, market adoption is expected to accelerate across regions. While North America and Europe continue to lead, the Asia-Pacific region holds immense potential for future growth. Strategic focus on innovation, affordability, and access will be key to capitalizing on global opportunities.

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.